CVS Health Stock Is Soaring. Could the Rally Just Be Getting Started?

CVS Health (NYSE: CVS) whitethorn conscionable person the medicine for your investing needs if you're looking for semipermanent growth. The shares of the nation's largest pharmacy concatenation had been overlooked until recently, due to the fact that of the company's bladed margins and comparatively dilatory growth.

However, implicit the past month, CVS banal has risen by astir 24%. That's acknowledgment to a beardown first-quarter net report, a turnaround successful its worst-performing segment, and consequent expert upgrades.

Here are 3 reasons wherefore the rally for this healthcare institution whitethorn person immoderate legs, and 1 crushed to inactive beryllium cautious.

Earnings and guidance person improved

In the archetypal quarter, reported gross jumped 6.2% twelvemonth implicit twelvemonth to $100.4 billion, portion net per stock (EPS) were $2.30, up 62% implicit the aforesaid play a twelvemonth ago. Both numbers amazed analysts, who had predicted gross of $94.4 cardinal and EPS of $1.93.

The upbeat study led the institution to rise its full-year guidance. EPS is present predicted to beryllium betwixt $6.24 and $6.44, up 4.9% astatine the midpoint, and adjusted EPS is expected to beryllium betwixt $7.30 and $7.50, up 4.2% astatine the midpoint. The institution besides said it present expects currency travel from operations to beryllium astatine slightest $9.5 billion, up from $9 billion.

The dividend output is inactive rather charismatic

CVS offers a dividend, astatine its existent stock price, of astir 2.8%, much than treble the mean dividend of the S&P 500. The company's consistently precocious escaped currency travel allows it to support its payouts. In caller fiscal years, CVS has generated operating currency travel hovering betwixt $9 cardinal and $10.5 billion.

Its security conception is bouncing backmost

CVS is simply a one-stop store for aesculapian needs. It's a pharmacy company, but it besides offers healthcare security done its ownership of Aetna, and it's a pharmacy benefits manager done its ownership of Caremark. The 3 businesses springiness the institution a vertically integrated healthcare ecosystem.

This loop creates a antiaircraft moat that pure-play retailers (such arsenic Walgreens) and pure-play insurers (such arsenic Humana) cannot easy replicate, positioning CVS to seizure margins astatine aggregate points of the healthcare worth chain.

The wellness attraction benefits segment, which includes Aetna, saw gross emergence 3.3% twelvemonth implicit twelvemonth to $35.9 billion.

The rising aesculapian utilization costs successful the Aetna wellness security portion person been curbed, allowing amended margins. Aetna's aesculapian payment ratio (MBR) -- the percent of premiums spent connected aesculapian claims -- dropped sharply to 84.6% from 87.3% successful the anterior year's quarter. Those profits were helped by CVS' determination to exit money-losing Affordable Care Act idiosyncratic exchanges successful 2026, sacrificing low-margin rank measurement to rescue its wide security profitability.